July 08, 2021 2 min read Save Source/Disclosures Published by: Disclosures: Eikelboom reports he received consultant fees and grant support from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi-Sankyo, Eli Lilly, GlaxoSmithKline, Janssen, Pfizer, Sanofi and Servier. Halperin reports he consulted for Bayer HealthCare, Boehringer Ingelheim and Ortho-McNeil-Janssen and has served on the steering committee of the CATALYST trial sponsored by Abbott.